A recent study suggested that TGF-β-mediated NLRP3 inflammasome activation may trigger the release of high-mobility group box 1, thereby exacerbating the pathological progression of Ang II-induced renal fibrosis in hypertensive nephropathy. Here, NLRP3 is linked to hypertensive nephropathy.